Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:October 11, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:October 11, 2016Unknown status
Condition(s):Solid TumoursLast Updated:August 1, 2018Unknown status
Condition(s):Safety and EfficacyLast Updated:January 13, 2023Terminated
Condition(s):Recurrent GlioblastomaLast Updated:January 22, 2021Unknown status
Condition(s):Solid Tumor; Hepatocellular Carcinoma; Colorectal Cancer; GliomaLast Updated:September 23, 2020Unknown status
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome; Multiple MyelomaLast Updated:June 1, 2018Completed
Condition(s):CRC; Solid TumorLast Updated:May 19, 2022Recruiting
Condition(s):Gastric Cancer; Pancreatic Cancer; Solid TumorLast Updated:February 8, 2023Recruiting
Condition(s):Advanced Solid TumorsLast Updated:August 4, 2023Recruiting
Condition(s):Gastric Cancer; Pancreatic Cancer; Solid TumorLast Updated:November 18, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.